Tags: fda | approves | hepc | drug

FDA Approves Breakthrough Hepatitis C Drug

Friday, 06 Dec 2013 05:40 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi, also known as sofosbuvir, as a treatment for chronic infection with the liver-destroying hepatitis C virus.

The pill is the first approved to treat certain types of hepatitis C infection without the need for interferon, an injected drug that can cause severe flu-like symptoms.

Hepatitis C, which is often undiagnosed, affects about 3.2 million Americans, killing more than 15,000 each year, mostly from illnesses such as cirrhosis and liver cancer.

Gilead said Sovaldi can be used in combination with ribavirin, an older antiviral pill, for patients with genotypes 2 and 3 infections, which account for about 28 percent of U.S. patients infected with the virus.

For patients with genotypes 1 or 4, the new drug needs to be used with both interferon and ribavirin, although it can be considered for use in patients with genotype 1 infections who cannot use interferon.

Gilead has estimated that around 70 percent of U.S. patients have genotype 1 hepatitis C infections.

The drug's approval was supported by several studies showing that it helped to eradicate the virus in significantly more patients, with fewer side effects, than the current drug regimen.

Sovaldi is the first in a new class of medications known as nucleotide analogue inhibitors, or "nukes," designed to block a specific protein that the hepatitis C virus needs to copy itself.

Analysts, on average, have forecast Sovaldi sales of $1.9 billion next year, according to BMO Capital Markets.

Shares of Gilead, which have nearly doubled over the past 12 months, were little changed in after-hours trading. The shares rose 1 percent to close at $73.99 in regular Nasdaq trading on Friday.

 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Ferguson Rally Marks 3 Weeks Since Brown's Death

Saturday, 30 Aug 2014 15:40 PM

Hundreds converged on Ferguson on Saturday to march for Michael Brown, the unarmed black 18-year-old who was shot and ki . . .

St. Louis Officer Retires Amid Probe of 'Killer' Video

Saturday, 30 Aug 2014 15:27 PM

Police say a suspended St. Louis County officer who had been assigned to patrols in Ferguson has retired amid a review o . . .

Border Patrol Agent Fires at Armed Militia Member

Friday, 29 Aug 2014 20:14 PM

A Border Patrol agent pursuing a group of immigrants in a wooded area near the Texas-Mexico border on Friday fired sever . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved